GL1X · GenesisL1 explorer

Research workbench

Crystal structure of VP9 from white spot syndrome virus

Analyse Crystal structure of VP9 from white spot syndrome virus in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2GJ2
Type
protein
Length
316 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
WSV230
UniProt
Q91LD0
Ligands
CD
Pockets
5 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 16% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DWSV230protein7916% helix, 33% strandQ91LD0

Ligands and binding sites

  • CD · Cadmium ion · metal · 8 copies · chains A, D, B, C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1690.470.8420CD
2700.410.8021CD
3790.350.7619CD
4660.330.7618empty
5820.330.7520empty

Interfaces

2 interfaces between chains.

  • A–D · 479 Ų buried · 5 hydrogen bonds · protein-protein
  • B–C · 468 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 2GJ2 · Crystal Structure of VP9 from White Spot Syndrome Virus · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.